Expression of P-REX2a is associated with poor prognosis in endometrial malignancies

P-REX2a is a PTEN inhibitor that also activates Rac 1. No associations with P-REX2a and human endometrial cancers have been reported to date. In this study, we immunohistochemically analyzed 155 uterine endometrial malignancies for P-REX2a expression. The P-REX2a-positive tumors displayed worse prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeshita, Sho, Yamashita, Yoriko, Shiomi, Kosuke, Suzuki, Nako, Yoshida, Jun, Naiki-Ito, Aya, Suzuki, Shugo, Akatsuka, Shinya, Toyokuni, Shinya, Takahashi, Takashi, Mase, Shoko, Arakawa, Atsushi, Sugiura-Ogasawara, Mayumi, Takahashi, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973852/
https://www.ncbi.nlm.nih.gov/pubmed/29872505
http://dx.doi.org/10.18632/oncotarget.25349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973852/
https://www.ncbi.nlm.nih.gov/pubmed/29872505
http://dx.doi.org/10.18632/oncotarget.25349

Ejemplares similares